Essential involvement of cross-talk between IFN-γ and TNF-α in CXCL10 production in human THP-1 monocytes

Journal of Cellular Physiology

Volumn 220, Issue 3, 2009, Pages 690-697

  Qi, Xu Feng ^a   Kim, Dong Heui ^a   Yoon, Yang Suk ^a   Jin, Dan ^b   Huang, Xue Zhu ^c   Li, Jian Hong ^d   Deung, Young Kun ^a   Lee, Kyu Jae ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Hubei Province Key Laboratory of Refractories and Ceramics   (China)

^c YANBIAN UNIVERSITY   (China)

^d HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CXCL10 PROTEIN, HUMAN; I KAPPA B; JAK1 PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN KINASE INHIBITOR; RECOMBINANT PROTEIN; STAT1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONOCYTE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE; CHEMOKINE CXCL10; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; I-KAPPA B PROTEINS; INTERFERON-GAMMA; JANUS KINASE 1; JANUS KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 67650379094     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21815     Document Type: Article

References (43)

1. Asensio VC, Maier J, Milner R, Boztug K, Kincaid C, Moulard M, Phillipson C, Lindsley K, Krucker T, Fox HS, Campbell IL. 2001. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 75:7067-7077.
2. Baron M, Davignon JL. 2008. Inhibition of IFN-γamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. J Immunol 181:5530-5536.
3. Brightling CE, Ammit AJ, Kaur D, Black JL, Wardlaw AJ, Hughes JM, Bradding P. 2005. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171:1103-1108.
4. Briscoe J, Rogers NC, Witthuhn BA, WatlingD,Harpur AG, Wilks AF, Stark GR, Ihle JN, Kerr IM. 1996. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state. EMBO J 15:799-809.
5. Digicaylioglu M, Lipton SA. 2001. Erythropoietin-mediated neuroprotection involves crosstalk between Jak2 and NF-kappaB signalling cascades. Nature 412:641-647.
6. Donato NJ, Gallick GE, Steck PA, Rosenblum MG. 1989. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity. J Biol Chem 264:20474-20481.
7. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, Girolomoni G, Pastore S. 2001. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 107:871-877.
8. Goh KC, Haque SJ, Williams BR. 1999. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 18:5601-5608.
9. Held TK, Weihua X, Yuan L, Kalvakolanu DV, Cross AS. 1999. Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun 67:206-212.
10. Hu J, Nakano H, Sakurai H, Colburn NH. 2004. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis 25:1991-2003.
11. Incorvaia C, Frati F, Verna N, D'Alo S, MotoleseA, Pucci S. 2008. Allergy and the skin.Clin Exp Immunol 153:27-29.
12. Kanda N, Watanabe S. 2007. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148:2317-2325.
13. Kanda N, Shimizu T, Tada Y, Watanabe S. 2007. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 37:338-350.
14. Kim KW, Kim SH, Lee EY, Kim ND, Kang HS, Kim HD, Chung BS, Kang CD. 2001. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells. J Biol Chem 276:13186-13191.
15. Kim JH, Na HJ,Kim CK, Kim JY, Ha KS, Lee H, Chung HT, KwonHJ, Kwon YG, Kim YM. 2008. The non-provitamin A carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-kappaB-inducing kinase pathways: Role of H(2)O(2) in NF-kappaB activation. Free Radical Biol Med 45:885-896.
16. Komine M, Kakinuma T, Kagami S,Hanakawa Y,Hashimoto K, Tamaki K. 2005. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 125:491-498.
17. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
18. Larner AC, Petricoin EF, Nakagawa Y, Finbloom DS. 1993. IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma-induced cellular gene expression in monocytes and monocytic cell lines. J Immunol 150:1944-1950.
19. Lombardi A, Cantini G, Piscitelli E, Gelmini S, Francalanci M, Mello T, Ceni E, Varano G, Forti G, Rotondi M, Galli A, Serio M, Luconi M. 2008. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. Arterioscler Thromb Vasc Biol 28:718-724.
20. Luster AD, Ravetch JV. 1987. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166:1084-1097.
21. Luster AD, Unkeless JC, Ravetch JV. 1985. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672-676.
22. Lykouras D, Sampsonas F, Kaparianos A, Karkoulias K, Spiropoulos K. 2008. Role and pharmacogenomics of TNF-alpha in asthma. Mini Rev Med Chem 8:934-942.
23. Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. 2009. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 29: 57-62.
24. Majumder S, Zhou LZ, Chaturvedi P, Babcock G, Aras S, Ransohoff RM. 1998. p48/STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha. J Immunol 161:4736-4744.
25. Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD. 2002. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168:5278-5286.
26. Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR, David M. 2001. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104:731-741.
27. Nguyen VA, Chen J, Hong F, Ishac EJ, Gao B. 2000. Interferons activate the p42/44 mitogenactivated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: Differential regulation by acute ethanol via a protein kinase C-dependent mechanism. Biochem J 349:427-434.
28. Panzer U, ZahnerG,WienbergU, Steinmetz OM, Peters A, Turner JE, Paust HJ, WolfG, Stahl RA, Schneider A. 2008. 15-deoxy-delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. Nephrol Dial Transplant 23:3776-3785.
29. Rose DM, Winston BW, Chan ED, Riches DW, Henson PM. 1997. Interferon-gamma and transforming growth factor-beta modulate the activation of mitogen-activated protein kinases and tumor necrosis factor-alpha production induced by Fc gamma-receptor stimulation in murine macrophages. Biochem Biophys Res Commun 238:256-260.
30. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883.
31. Sareila O, Hamalainen M, Nissinen E, Kankaanranta H, Moilanen E. 2008. Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli. J Pharmacol Exp Ther 324:858-866.
32. Sato E, Fujimoto J, Toyoki H, Sakaguchi H, Alam SM, Jahan I, Tamaya T. 2007. Expression of IP-10 related to angiogenesis in uterine cervical cancers. Br J Cancer 96:1735-1739.
33. Schaffer M, Bongartz M, HoffmannW, Viebahn R. 2006. Regulation of nitric oxide synthesis in wounds by IFN-gamma depends on TNF-alpha. J Invest Surg 19:371-379.
34. Schouten GJ, Vertegaal AC, Whiteside ST, Israel A, Toebes M, Dorsman JC, van der Eb AJ, Zantema A. 1997. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J 16:3133-3144.
35. Shen H, Lentsch AB. 2004. Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production ofCXCchemokines.AmJ Physiol Cell Physiol 286:C840-C847.
36. Song R, Ning W, Liu F, Ameredes BT, Calhoun WJ,Otterbein LE, Choi AM. 2003. Regulation of IL-1beta-induced GM-CSF production in human airway smooth muscle cells by carbon monoxide. Am J Physiol Lung Cell Mol Physiol 284:L50-L56.
37. Sung B, Pandey MK, Nakajima Y, Nishida H, Konishi T, Chaturvedi MM, Aggarwal BB. 2008. Identification of a novel blocker of IkappaB alpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB. Mol Cancer Ther 7:191-201.
38. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 177:1809-1814.
39. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 14:2876-2883.
40. Vanguri P, Farber JM. 1990. Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. J Biol Chem 265:15049-15057.
41. Vila-del Sol V, Punzon C, Fresno M. 2008. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 181:4461-4470.
42. Villagomez MT, Bae SJ, Ogawa I, Takenaka M, Katayama I. 2004. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis. Br J Dermatol 150:910-916.
43. Xiao T, Kagami S, Saeki H, Sugaya M, Kakinuma T, Fujita H, Yano S, Mitsui H, Torii H, Komine M, Asahina A, Nakamura K, Tamaki K. 2003. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J Dermatol Sci 31:111-117.